For the Inventor, By the Inventor

Enter assignee name

San Ramon, CA, United States of America

Odyssey Thera Inc.

USPTO Granted Patents = 16

% Expired Patents = 81.3

EPO Patents = 5

Forward Citations = 105

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Stephen William Watson Michnick (15 out of 18 patents)

Ingrid Remy (7 out of 10 patents)

Marnie L MacDonald (6 out of 6 patents)

4. Jane Lamerdin (5 out of 5 patents)

5. John K Westwick (4 out of 5 patents)

6. Joelle Nina Pelletier (4 out of 6 patents)

7. Helen Yu (2 out of 7 patents)

8. Andreas Plückthun (2 out of 19 patents)

9. Joelle Nina Polletier (2 out of 2 patents)

10. Katja M Arndt (2 out of 2 patents)

11. André Galarneau (1 out of 1 patent)

12. Brigitte Keon (1 out of 1 patent)

13. Normand Brisson (1 out of 3 patents)

14. André Galarneau (1 out of 1 patent)

15. Stephen W Michnick (1 patent)

16 patents: Sort by Forward Citations

1. 8192944 - Protein fragment complementation assays for the detection of biological or drug interactions (2012-06-05),

2. 8101364 - Fragments of fluorescent proteins for protein fragment complementation assays (2012-01-24),

3. 7989218 - Protein fragment complementation assays for the detection of biological or drug interactions (2011-08-02),

4. 7955832 - [object Object] (2011-06-07),

5. 7935493 - Protein fragment complementation assays for high-throughput and high-content screening (2011-05-03),

6. 7855167 - In vivo screening of protein-protein interactions with protein-fragment complementation assays (2010-12-21),

7. 7625700 - [object Object] (2009-12-01),

8. 7488583 - Fragment complementation assays for G-protein-coupled receptors and their signaling pathways (2009-02-10),

9. 7306914 - Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy (2007-12-11),

10. 7166424 - Fragments of fluorescent proteins for protein fragment complementation assays (2007-01-23),

11. 7160691 - Protein fragment complementation assays for the detection of biological or drug interactions (2007-01-09),

12. 7062219 - Protein fragment complementation assays for high-throughput and high-content screening (2006-06-13),

13. 6929916 - Protein fragment complementation assays for the detection of biological or drug interactions (2005-08-16),

14. 6897017 - Vivo library-versus-library selection of optimized protein-protein interactions (2005-05-24),

15. 6872871 - Mapping molecular interactions in plants with protein fragments complementation assays (2005-03-29),

Odyssey Thera Inc. is a leading biotechnology company focused on advancing drug discovery and development through innovative cellular signaling analysis tools. The company utilizes proprietary high-throughput screening technology to rapidly evaluate and optimize drug candidates for a wide range of therapeutic areas. Odyssey Thera's expertise lies in identifying novel drug targets, mode of action analysis, and personalized medicine solutions. With a strong commitment to scientific excellence and collaboration, Odyssey Thera is driving advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Odyssey Thera Inc.

16 Patents

#15 in San Ramon, CA

#4,767 in California

#19,898 in US

#37,766 in the World

San Ramon, CA, United States of America

Odyssey Thera Inc.

Forward Citations = 105

14 inventors:

Stephen William Watson Michnick (15 out of 18 patents)

Ingrid Remy (7 out of 10 patents)

Marnie L MacDonald (6 out of 6 patents)

4. Jane Lamerdin (5 out of 5 patents)

5. John K Westwick (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…